Hydrocephalus diagnostic study of choice

Jump to navigation Jump to search

Hydrocephalus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hydrocephalus diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hydrocephalus diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Hydrocephalus diagnostic study of choice

CDC on Hydrocephalus diagnostic study of choice

Hydrocephalus diagnostic study of choice in the news

Blogs onHydrocephalus diagnostic study of choice

Directions to Hospitals Treating Hydrocephalus

Risk calculators and risk factors for Hydrocephalus diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]

Overview

Diagnostic Study of Choice

Study of choice

  • MRI is the gold standard test for the diagnosis of hydrocephalus, the findings are given below:[1][2][3]
  • Ventricular enlargement not entirely attributable to cerebral atrophy or congenital enlargement (Evans index >0.3).
  • No macroscopic obstruction to CSF flow.

At least one of the following supportive features: Enlargement of the temporal horns of the lateral ventricles not entirely attributable to hippocampus atrophy.

  • Callosal angle of 40º or greater.
  • Evidence of altered brain water content, including periventricular signal changes on CT and MRI not attributable to microvascular ischemic changes or demyelination.
  • An aqueductal or fourth ventricular flow void.

References

  1. Bradley WG (April 2016). "Magnetic Resonance Imaging of Normal Pressure Hydrocephalus". Semin. Ultrasound CT MR. 37 (2): 120–8. doi:10.1053/j.sult.2016.01.005. PMID 27063662.
  2. Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, Nakajima M, Hashimoto M, Kuriyama N, Tokuda T, Ishii K, Kaijima M, Hirata Y, Saito M, Arai H (2012). "Guidelines for management of idiopathic normal pressure hydrocephalus: second edition". Neurol. Med. Chir. (Tokyo). 52 (11): 775–809. PMID 23183074.
  3. Agarwal A, Bathla G, Kanekar S (April 2016). "Imaging of Communicating Hydrocephalus". Semin. Ultrasound CT MR. 37 (2): 100–8. doi:10.1053/j.sult.2016.02.007. PMID 27063660.

Template:WH Template:WS